Loading...
Revisiting pars plana vitrectomy in the primary treatment of diabetic macular edema in the era of pharmacological treatment
Diabetic macular edema (DME) is the most common cause of moderate visual loss in diabetic patients. The current treatment of choice for center-involved DME is anti-vascular endothelial growth factor (VEGF) treatment. Most patients that undergo pharmacological inhibition with anti-VEGF agents need mu...
Na minha lista:
| Udgivet i: | Taiwan J Ophthalmol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Wolters Kluwer - Medknow
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6947753/ https://ncbi.nlm.nih.gov/pubmed/31942427 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/tjo.tjo_61_19 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|